Předmět: |
|
Zdroj: |
NewsRx COVID-19 Weekly; 2/27/2023, p43-43, 1p |
Abstrakt: |
For more information on this research see: Predictors of Poor Outcome In Tocilizumab Treated Patients With Sars-cov-2 Related Severe Respiratory Failure: a Multicentre Real World Study. Keywords: Florence; Italy; Europe; Biotechnology; COVID-19; Coronavirus; Drugs and Therapies; Health and Medicine; Hospitals; Immunologic Agents; Immunotherapy; Monoclonal Antibodies; Mortality; Pharmaceuticals; RNA Viruses; Risk and Prevention; SARS-CoV-2; Severe Acute Respiratory Syndrome Coronavirus 2; Tocilizumab Therapy; Viral; Virology EN Florence Italy Europe Biotechnology COVID-19 Coronavirus Drugs and Therapies Health and Medicine Hospitals Immunologic Agents Immunotherapy Monoclonal Antibodies Mortality Pharmaceuticals RNA Viruses Risk and Prevention SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2 Tocilizumab Therapy Viral Virology 2023 MAR 3 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx COVID-19 Weekly -- Investigators publish new report on Coronavirus - COVID-19. [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|